Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide
Status:
Not yet recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The overarching goal of this study is to examine the acute vasoreactive response to both
inhaled nitric oxide and inhaled epoprostenol across both traditionally and non-traditionally
interrogated phenotypes in PH, and to further characterize the relationship of vasoreactivity
to disease severity and PH phenotype.